Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK and OMAHA, Neb., May 23, 2022 (GLOBE NEWSWIRE) -- Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that...
-
With a single administration, XVIR-210, a nano-formulated prodrug of tenofovir, provided drug levels sufficient for chronic HBV treatment, HIV treatment, and HIV prophylaxis for over two months in...
-
With a single administration, XVIR-110, a nano-formulated prodrug integrase inhibitor, provided year-long plasma drug levels sufficient for HIV treatment and prophylaxis in animal models Studies...
-
Sellbyville, Delaware, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Global Antidiabetics Market will surpass USD 110 billion by 2024; according to a new research report by Global Market Insights, Inc....
-
Ocean View, Delaware, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Antidiabetics Market is poised to reach USD 110 billion by 2024; according to a new research report by Global Market Insights, Inc....